KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Sales (2016 - 2025)

Historic Return on Sales for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to 0.09%.

  • BeOne Medicines' Return on Sales rose 2100.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.17% for FY2024, which is 1900.0% up from last year.
  • BeOne Medicines' Return on Sales amounted to 0.09% in Q3 2025, which was up 2100.0% from 0.07% recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Return on Sales registered a high of 0.28% during Q3 2023, and its lowest value of 3.2% during Q2 2021.
  • For the 5-year period, BeOne Medicines' Return on Sales averaged around 0.84%, with its median value being 0.58% (2023).
  • As far as peak fluctuations go, BeOne Medicines' Return on Sales skyrocketed by 71200bps in 2021, and later tumbled by -15300bps in 2022.
  • BeOne Medicines' Return on Sales (Quarter) stood at 2.76% in 2021, then surged by 58bps to 1.17% in 2022, then soared by 51bps to 0.58% in 2023, then surged by 77bps to 0.13% in 2024, then surged by 166bps to 0.09% in 2025.
  • Its Return on Sales was 0.09% in Q3 2025, compared to 0.07% in Q2 2025 and 0.0% in Q1 2025.